Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement
08/06/2026 11:29
BRIEF-Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement June 8 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK:
ENTERS HUADONG MEDICINE SUPPLY AGREEMENT ON JUNE 8, 2026
HUADONG MEDICINE SUPPLY CAP SET AT RMB100 MILLION UNTIL DEC 31, 2026
UNDER DEAL, GRAND PHARM (CHINA) TO SUPPLY PHARMACEUTICAL PREPARATIONS, RAW MATERIALS, OTHERS TO HUADONG MEDICINE, OTHERS
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement